How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?

Multiple sclerosis (MS) is a neurological disorder characterized by inflammatory demyelination and neurodegeneration in the central nervous system. Until recently, disease-modifying treatment was based on agents requiring parenteral delivery, thus limiting long-term compliance. Basic treatments such...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Fazekas, Franz, Bajenaru, Ovidiu, Berger, Thomas, Fabjan, Tanja Hojs, Ledinek, Alenka Horvat, Jakab, Gábor, Komoly, Samuel, Kobys, Tetiana, Kraus, Jörg, Kurča, Egon, Kyriakides, Theodoros, Lisý, L'ubomír, Milanov, Ivan, Nehrych, Tetyana, Moskovko, Sergii, Panayiotou, Panayiotis, Jazbec, Saša Šega, Sokolova, Larysa, Taláb, Radomír, Traykov, Latchezar, Turčáni, Peter, Vass, Karl, Vella, Norbert, Voloshyná, Nataliya, Havrdová, Eva
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2013
Teme:
Neuroscience
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640198/
https://ncbi.nlm.nih.gov/pubmed/23641231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2013.00010
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki